Gene · 4922
Papers2,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mas-Related G-Protein-Coupled Receptors: Emerging Roles in Neuropathic Pain. | Biomolecules | 2026 | 41750358 | PubTator, text mining | PubMed |
| MicroRNA Signatures of Prostate Cancer Spheroids in Microfluidic Culture Under Hormone-Deprivation Conditions. | Bioengineering (Basel) | 2026 | 41749743 | PubTator, text mining | PubMed |
| Molecular mechanisms and classification of castration-resistant prostate cancer: Insights into androgen receptor, cancer stem cells, and neuroendocrine features. | Curr Urol | 2026 | 41743916 | PubTator, text mining | PubMed |
| Neuropeptides neurotensin and substance P accelerate diabetic wound healing by modulating immunity and the skin microbiome. | Sci Rep | 2026 | 41702954 | PubTator, text mining | PubMed |
| Neurotensin in the extended amygdala maintains wakefulness in novel environments. | Proc Natl Acad Sci U S A | 2026 | 41650227 | PubTator, text mining | PubMed |
| Tai Chi rehabilitation program enhances blood pressure control and modulates inflammatory and Brain-Gut peptides in hypertension. | BMC Complement Med Ther | 2026 | 41634677 | PubTator, text mining | PubMed |
| VTA-forebrain connectivity moderates adaptive behavior. | Brain Struct Funct | 2026 | 41632292 | PubTator, text mining | PubMed |
| Neuroimmune circuits in respiratory pathophysiology: decoding molecular crosstalk for precision therapeutic targeting. | Ann Med | 2026 | 41601146 | PubTator, text mining | PubMed |
| What Drives Aggressiveness of Smoker Lung Adenocarcinoma? Potential Role of Nicotine-Responsive Neuropeptides Neurotensin and Calcitonin-Related Polypeptide Alpha. | OMICS | 2026 | 41457853 | PubTator, text mining | PubMed |
| Recent Developments in Capillary and Microchip Electroseparations of Peptides (2023-mid 2025). | Electrophoresis | 2026 | 41199492 | PubTator, text mining | PubMed |
| Neurotensin drives theca cell migration during ovulation in primates†. | Biol Reprod | 2026 | 41014186 | PubTator, text mining | PubMed |
| Structure-based design of macrocyclic peptides to generate functional antibodies against G protein-coupled receptors. | Nat Commun | 2025 | 41387675 | PubTator, text mining | PubMed |
| The Involvement of the Peptidergic Systems in Breast Cancer Development. | Cancers (Basel) | 2025 | 41301028 | PubTator, text mining | PubMed |
| Comparative study evaluating the efficacy of duloxetine, gabapentin, and lacosamide on oxaliplatin-induced peripheral neuropathy. | Pain Rep | 2025 | 41255847 | PubTator, text mining | PubMed |
| The rs139226362 (delGATT) variant in the NTS gene alters plasma neurotensin levels in schizophrenia. | Biomark Med | 2025 | 41251017 | PubTator, text mining | PubMed |
| Capillary Electrophoresis as a Useful Tool to Separate Isomeric Opioid-Neurotensin Hybrid Peptides. | Molecules | 2025 | 41226149 | PubTator, text mining | PubMed |
| MRPL51 expression is associated with poor prognosis and regulates lung adenocarcinoma progression via neurotensin. | J Thorac Dis | 2025 | 41158381 | PubTator, text mining | PubMed |
| Neuropeptides, Altruism, and Adverse Childhood Experiences: Investigating Biological and Behavioral Correlations in Medical Students. | Brain Sci | 2025 | 41154222 | PubTator, text mining | PubMed |
| Structure-activity relationships of contulakin-G: Design, synthesis, and characterization of Thr10 analogs for pain modulation. | Biomed Pharmacother | 2025 | 41130099 | PubTator, text mining | PubMed |
| Molecular Dynamics of Neurotensin and Lysozyme Soft-Landing on Gold: Influence of the Molecular Projectile Velocity, Incidence Angle and Temperature. | J Am Soc Mass Spectrom | 2025 | 41070862 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4922/papers?page=2